Lista de obras - Matthias Barton - Dominio Público Uruguay

17Beta-estradiol acutely improves endothelium-dependent relaxation to bradykinin in isolated human coronary arteries

scientific article published on 01 November 1998

Activation of Pro-Inflammatory and Anti-Inflammatory Cytokines in Host Organs During Chronic Allograft Rejection: Role of Endothelin Receptor Signaling

scientific article published on 01 May 2005

Aging and biomedicine 2005: where should we go from here?

scientific article published on 01 May 2005

Alike but not the same: anatomic heterogeneity of estrogen receptor-mediated vasodilation.

artículo científico publicado en 2013

Anatomically distinct activation of endothelin-3 and the L-arginine/nitric oxide pathway in the kidney with advanced aging.

artículo científico publicado en 2005

Childhood obesity: a life-long health risk ⬇️

artículo científico publicado el 1 de febrero de 2012

Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780.

artículo científico publicado en 2010

Distinct roles of estrogen receptors alpha and beta mediating acute vasodilation of epicardial coronary arteries

scientific article published on 30 April 2007

ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis

artículo científico publicado en 2009

Early life stress determines insulin signalling in adulthood

scientific article published on 13 January 2020

Effects of obesity on mortality in patients with unstable angina or non-ST-elevation myocardial infarction

artículo científico publicado en 2007

Endothelial therapy of atherosclerosis and its risk factors

artículo científico publicado en 2003

Endothelin XII ⬇️

artículo científico publicado el 26 de julio de 2012

Endothelin antagonists for hypertension and renal disease.

artículo científico publicado en 1999

Endothelin in coronary artery disease and myocardial infarction.

artículo científico publicado en 2013

Endothelin in heart failure.

artículo científico publicado en 1999

Endothelin inhibition delays onset of hyperglycemia and associated vascular injury in type I diabetes: evidence for endothelin release by pancreatic islet beta-cells

artículo científico publicado en 2005

Endothelin, hypercholesterolemia and atherosclerosis

artículo científico publicado en 2003

Endothelin: 20 years from discovery to therapy

artículo científico publicado en 2008

Fat intake and cardiovascular response.

artículo científico publicado en 2008

Getting radical about obesity: new links between fat and heart disease.

artículo científico publicado en 2009

In Memoriam: Paul M. Vanhoutte

artículo científico publicado en 2019

Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis

artículo científico publicado en 2001

Long-term effects of endovascular angioplasty on orthostatic vasocutaneous autoregulation in patients with peripheral atherosclerosis

artículo científico publicado en 2006

Lovastatin stimulates human vascular smooth muscle cell expression of bone morphogenetic protein-2, a potent inhibitor of low-density lipoprotein-stimulated cell growth.

artículo científico publicado en 2003

Lung cancer and hormone replacement therapy

artículo científico publicado en 2010

Mechanisms and therapy of atherosclerosis and its clinical complications.

artículo científico publicado en 2013

Native and oxidized low-density lipoproteins stimulate endothelin-converting enzyme-1 expression in human endothelial cells.

artículo científico publicado en 2005

Non-genomic regulation of vascular cell function and growth by estrogen.

artículo científico publicado en 2009

Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis.

artículo científico publicado en 2010

Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors.

artículo científico publicado en 2011

Position paper: The membrane estrogen receptor GPER – Clues and questions ⬇️

artículo científico publicado el 10 de abril de 2012

Postmenopausal hypertension: mechanisms and therapy.

scientific article published on 26 May 2009

Postural effects on interstitial fluid pressure in humans

artículo científico publicado en 2006

Prevention and endothelial therapy of coronary artery disease.

artículo científico

Reversal of proteinuric renal disease and the emerging role of endothelin.

scientific article published on 22 July 2008

Role of endothelin receptors for renal protection and survival in hypertension: waiting for clinical trials

artículo científico publicado en 2006

Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.

artículo científico publicado en 2004

Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER.

artículo científico publicado en 2009

The First Tomoh Masaki Award (2011).

artículo científico publicado en 2012

The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function ⬇️

artículo científico publicado el 5 de julio de 2011

The G-protein-coupled estrogen receptor GPER in health and disease

artículo científico publicado en 2011

The Twelfth International Conference on Endothelin (ET-12), Cambridge 2011 ⬇️

artículo científico publicado el 26 de julio de 2012

The discovery of endothelium-dependent contraction: the legacy of Paul M. Vanhoutte.

artículo científico publicado en 2011

The future of endothelin research: scientific mentoring and beyond.

artículo científico publicado en 2012

The therapeutic potential of endothelin receptor antagonists in cardiovascular disease.

artículo científico publicado en 2001

Themed section: endothelin

artículo científico publicado en 2013

Therapeutic potential of endothelin receptor antagonists for chronic proteinuric renal disease in humans.

artículo científico publicado en 2010

Transcriptional regulation of vascular bone morphogenetic protein by endothelin receptors in early autoimmune diabetes mellitus

artículo científico publicado en 2005

Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.

artículo científico publicado en 2005

Lista de obras de Matthias Barton

17Beta-estradiol acutely improves endothelium-dependent relaxation to bradykinin in isolated human coronary arteries

Activation of Pro-Inflammatory and Anti-Inflammatory Cytokines in Host Organs During Chronic Allograft Rejection: Role of Endothelin Receptor Signaling

Aging and biomedicine 2005: where should we go from here?

Alike but not the same: anatomic heterogeneity of estrogen receptor-mediated vasodilation.

Anatomically distinct activation of endothelin-3 and the L-arginine/nitric oxide pathway in the kidney with advanced aging.

Childhood obesity: a life-long health risk ⬇️

Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780.

Distinct roles of estrogen receptors alpha and beta mediating acute vasodilation of epicardial coronary arteries

ERalpha, ERbeta, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis

Early life stress determines insulin signalling in adulthood

Effects of obesity on mortality in patients with unstable angina or non-ST-elevation myocardial infarction

Endothelial therapy of atherosclerosis and its risk factors

Endothelin XII ⬇️

Endothelin antagonists for hypertension and renal disease.

Endothelin in coronary artery disease and myocardial infarction.

Endothelin in heart failure.

Endothelin inhibition delays onset of hyperglycemia and associated vascular injury in type I diabetes: evidence for endothelin release by pancreatic islet beta-cells

Endothelin, hypercholesterolemia and atherosclerosis

Endothelin: 20 years from discovery to therapy

Fat intake and cardiovascular response.

Getting radical about obesity: new links between fat and heart disease.

In Memoriam: Paul M. Vanhoutte

Increased expression of endothelin-1 and inducible nitric oxide synthase isoform II in aging arteries in vivo: implications for atherosclerosis

Long-term effects of endovascular angioplasty on orthostatic vasocutaneous autoregulation in patients with peripheral atherosclerosis

Lovastatin stimulates human vascular smooth muscle cell expression of bone morphogenetic protein-2, a potent inhibitor of low-density lipoprotein-stimulated cell growth.

Lung cancer and hormone replacement therapy

Mechanisms and therapy of atherosclerosis and its clinical complications.

Native and oxidized low-density lipoproteins stimulate endothelin-converting enzyme-1 expression in human endothelial cells.

Non-genomic regulation of vascular cell function and growth by estrogen.

Obesity and aging: determinants of endothelial cell dysfunction and atherosclerosis.

Obesity, insulin resistance and diabetes: sex differences and role of oestrogen receptors.

Position paper: The membrane estrogen receptor GPER – Clues and questions ⬇️

Postmenopausal hypertension: mechanisms and therapy.

Postural effects on interstitial fluid pressure in humans

Prevention and endothelial therapy of coronary artery disease.

Reversal of proteinuric renal disease and the emerging role of endothelin.

Role of endothelin receptors for renal protection and survival in hypertension: waiting for clinical trials

Role of podocytes for reversal of glomerulosclerosis and proteinuria in the aging kidney after endothelin inhibition.

Signaling, physiological functions and clinical relevance of the G protein-coupled estrogen receptor GPER.

The First Tomoh Masaki Award (2011).

The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function ⬇️

The G-protein-coupled estrogen receptor GPER in health and disease

The Twelfth International Conference on Endothelin (ET-12), Cambridge 2011 ⬇️

The discovery of endothelium-dependent contraction: the legacy of Paul M. Vanhoutte.

The future of endothelin research: scientific mentoring and beyond.

The therapeutic potential of endothelin receptor antagonists in cardiovascular disease.

Themed section: endothelin

Therapeutic potential of endothelin receptor antagonists for chronic proteinuric renal disease in humans.

Transcriptional regulation of vascular bone morphogenetic protein by endothelin receptors in early autoimmune diabetes mellitus

Vascular consequences of menopause and hormone therapy: importance of timing of treatment and type of estrogen.